-- Days : -- HRS : -- MIN : -- SEC

Register for Free →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Josh J. Carlson, PhD, MPH

Articles by Josh J. Carlson, PhD, MPH

Diagnosis and Management of TRK Fusion Cancer

ByShivaani Kummar, MD, FACP,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Josh J. Carlson, PhD, MPH,Sean D. Sullivan, PhD, MSc, RPh,Ulrik Lassen, MD, PhD,Noah Federman, MD

January 11th 2022

Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer

ByJosh J. Carlson, PhD, MPH,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Noah Federman, MD,Ulrik Lassen, MD, PhD,Shivaani Kummar, MD, FACP,Sean D. Sullivan, PhD, MSc, RPh

January 11th 2022

Latest Updated Articles

Diagnosis and Management of TRK Fusion Cancer
January 11th 2022
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer
January 11th 2022

Trending on AJMC

Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%

Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36

Nephrologists Weigh Wins, Losses From 5 Years of Value-Based Kidney Care

Dialysis Access, Church CKD Screening Address Kidney Care Inequities

FSGS Treatment and Low IgAN Drug Uptake: Jai Radhakrishnan, MD, MS